UroGen Pharma

URGNNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.090 B

$42.76 -1.02%

Close of 22 Sept 2026

Revenue

$109.8M

#2473 by revenue

Earnings

-$153.5M

Loss-making

Shares outstanding

48,880,564

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#105Nuvation BioNUVB$2.14B
#106Braveheart BioBRVE$2.13B
#107UroGen PharmaURGN$2.09B
#108Agios PharmaceuticalsAGIO$2.09B
#109Nektar TherapeuticsNKTR$2.08B

What if UroGen Pharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$618,527.43

Per share 14,465× higher

Bitcoin $1.74T

$35,630.83

Per share 833× higher

Nvidia $5.52T

$112,841.72

Per share 2,639× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for UroGen Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.